Paid Clinical Trials Indianapolis
Discover 871 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Sponsor:
Sabine Mueller, MD, PhD
Location:
Code:
NCT05465174
Conditions
Craniopharyngioma, Child
Craniopharyngioma
Recurrent Craniopharyngioma
Eligibility Criteria
Sex: All
Age: 1 - 39
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Tovorafenib
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell LymphomaA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT06091865
Conditions
Diffuse Large B-cell Lymphoma (DLBCL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Odronextamab
Rituximab
Cyclophosphamide
Doxorubicin
Vincristine
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune DiseaseTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06293365
Conditions
Sjögrens Disease
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
VAY736 1ml PFS
VAY736 2 ml PFS
VAY736 2ml AI
Study of LP-184 in Patients with Advanced Solid TumorsStudy of LP-184 in Patients with Advanced Solid Tumors
Sponsor:
Lantern Pharma Inc.
Location:
Code:
NCT05933265
Conditions
Advanced Solid Tumor
Metastatic Solid Tumor
GBM
TNBC - Triple-Negative Breast Cancer
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LP-184
Spironolactone
Olaparib
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
Sponsor:
Theratechnologies
Location:
Code:
NCT05388474
Conditions
HIV Infections
Multi-Antiviral Resistance
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
No ibalizumab or Pre-ibalizumab treatment
On ibalizumab treatment
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)
Sponsor:
Biogen
Location:
Code:
NCT05531565
Conditions
Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Litifilimab
Placebo
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Sponsor:
Children's Oncology Group
Location:
Code:
NCT05235165
Conditions
Metastatic Malignant Neoplasm in the Lung
Metastatic Osteosarcoma
Osteosarcoma
Eligibility Criteria
Sex: All
Age: 0 - 50
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Questionnaire Administration
Thoracoscopy
Thoracotomy
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04530565
Conditions
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Blinatumomab
Bone Marrow Aspiration and Biopsy
Cyclophosphamide
Cytarabine
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus InfectionAdenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Sponsor:
New York Medical College
Location:
Code:
NCT03266627
Conditions
Adenovirus
Primary Immune Deficiency Disorder
Eligibility Criteria
Sex: All
Age: 1 - 70+
Healthy Volunteers: Not accepted
Interventions
cytotoxic t-lymphocytes